Bright Minds Biosciences (DRUG) Assets (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Assets of $224.35 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 492.1% from $37.89 million a year earlier but down 1.5% from the prior quarter.
Bright Minds Biosciences (DRUG) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bright Minds Biosciences posted Assets of $60.4 million.
- Assets has a five-year compound annual growth rate of 147.2% (FY2020 to FY2025).
- By fiscal year, Assets came in at $4.49 million in FY2024 (-12.0%), $5.1 million in FY2023 (-46.1%), $9.47 million in FY2022 (-40.3%) and $15.86 million in FY2021.
- Five-year quarterly Assets spans a low of $4.47 million in fiscal Q4 2024 and a high of $227.78 million in fiscal Q2 2026.
- Year over year, Assets has now increased in each of the last three quarters, with growth averaging 454.0% over the last seven quarters.
- The high point for year-over-year Assets in five years was fiscal Q1 2025 (growth of 726.4%); the low point was fiscal Q3 2022 (a decline of 61.7%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $227.78 million (Q2 2026), $65.17 million (Q1 2026) and $61.34 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.12 Bn | 1,135.70 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 647.48 Bn | 567.35 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 502.73 Bn | 475.84 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 363.86 Bn | 318.23 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.31 Bn | 267.30 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 269.08 Bn | 242.77 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 242.07 Bn | 197.46 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.93 Bn | 169.12 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Bright Minds Biosciences | 362.44 Mn | -201.15 Mn | - | 218.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218.41 Mn |
| Mar 31, 2026 | 224.27 Mn |
| Dec 31, 2025 | 66.36 Mn |
| Sep 30, 2025 | 60.66 Mn |
| Jun 30, 2025 | 38.37 Mn |
| Mar 31, 2025 | 39.46 Mn |
| Dec 31, 2024 | 40.70 Mn |
| Sep 30, 2024 | 4.52 Mn |
| Jun 30, 2024 | 4.58 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 5.21 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 6.39 Mn |
| Mar 31, 2023 | 7.39 Mn |
| Dec 31, 2022 | 8.52 Mn |
| Sep 30, 2022 | 8.84 Mn |
| Jun 30, 2022 | 6.85 Mn |
| Mar 31, 2022 | 9.42 Mn |
| Dec 31, 2021 | 12.09 Mn |
| Sep 30, 2021 | 15.71 Mn |
Bright Minds Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=DRUG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();